Jonty
I think it will be big, as the oral-care sector is a multi-billion dollar expanding glabal market that doesn't have the regulatory grief drug development brings.
An anecdotal example - Every month when I look in the toothpaste asle in the supermarket, there allways seems to be a trusted brand of toothpaste (ie- macleans, seredyne, colgate) announcing a a new ingredient/improvement - such as:
"new added germ fighters/whiteners/anti-plague agents, etc.
This market is big bucks and OBJ is in a position to give GSK a marketing edge - plus, of course, real product improvement (which OBJ is currently in the process of developing for GSK).
That's why I'm happy with the GSK part of the announcement.
- Forums
- ASX - By Stock
- WFL
- update
update, page-55
-
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable